Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.061 USD | -0.81% | -0.81% | -59.31% |
26/02 | Tanke Biosciences Corp Appoints Kenneth Marks to the Board of Directors | CI |
08/02 | Tanke Biosciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 1.35M 112M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net cash position 2021 | 39.68K 3.31M | Net Debt 2022 | 45.73K 3.82M | EV / Sales 2022 | - |
P/E ratio 2021 |
-21.5
x | P/E ratio 2022 |
-12.9
x | Employees | 130 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 23.04% |
1 day | -0.81% | ||
1 week | -0.81% | ||
Current month | -20.37% | ||
1 month | -20.37% | ||
3 months | -39.00% | ||
6 months | -39.00% | ||
Current year | -59.31% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Mills
CEO | Chief Executive Officer | - | 22/21/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Mills
CEO | Chief Executive Officer | - | 22/21/22 |
1st Jan change | Capi. | |
---|---|---|
-59.31% | 1.29M | |
+11.04% | 11.41B | |
-4.29% | 5.57B | |
-1.49% | 5B | |
+1.02% | 4.4B | |
-21.31% | 2.66B | |
-22.67% | 1.14B | |
-20.67% | 918M | |
-16.12% | 891M | |
+4.41% | 870M |
- Stock Market
- Equities
- TNBI Stock